Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Thoracic Malignancies
•
Medical Oncology
•
Thymoma and Thymic Carcinoma
For the neoadjuvant treatment for thymoma, when do you favor CAP with prednisone over CAP?
CAP with prednisone:
Kim et al., PMID 15140551
Answer from: Medical Oncologist at Academic Institution
Yes, due to the MD Anderson trial that used CAP+prednisone. However, there are no randomized data. I use carbo-taxol for thymic carcinoma.
Sign In
or
Register
to read more
31233
Related Questions
How do you typically approach adjuvant therapy for a Masaoka stage IVa thymoma post-R0 resection?
Is there any data on the safety or efficacy of combining osimertinib-based therapy with HER2-targeted treatment in patients with EGFR-mutant NSCLC and concurrent HER2-positive breast cancer?
Would you give consolidation durvalumab to a patient who underwent chemoradiation for his stage III NSCLC and is being started on antifibrotic therapy by pulmonology for his ILD?
Is DLL3 expression necessary for tarlatamab efficacy in small cell lung cancer?
In patients with resected stage II-III NSCLC, who completed adjuvant carboplatin and pemetrexed and are PD-L1 high, which immunotherapy would you offer?
Would you give durvalumab consolidation to a patient with stage III NSCLC with an STK11 mutation?
Would you give adjuvant sunvozertinib to patients with stage II-III NSCLC with an EGFR exon 20 insertion mutation?
What are your top takeaways in Thoracic Cancers from ASCO 2025?
In a patient with potentially resectable lung cancer experiencing severe pain due to chest wall invasion, would you consider palliative radiation therapy prior to neoadjuvant/perioperative chemoimmunotherapy?
How do you approach duration of immunotherapy in patients with metastatic NSCLC?